Author

Palle Bekker Jeppesen

ESPEN guidelines on chronic intestinal failure in adults
ESPEN guidelines on chronic intestinal failure in adults

Palle Bekker Jeppesen  et al.

THE LONG-ACTING GLP-2 ANALOG APRAGLUTIDE PROVIDES CLINICAL BENEFIT FOR PATIENTS WITH SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE AND COLON IN CONTINUITY AT 52 WEEKS
THE LONG-ACTING GLP-2 ANALOG APRAGLUTIDE PROVIDES CLINICAL BENEFIT FOR PATIENTS WITH SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE AND COLON IN CONTINUITY AT 52 WEEKS

Palle Bekker Jeppesen  et al.

APRAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOG, IMPROVES WET WEIGHT ABSORPTION IN SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE (SBS-IF) AND COLON-IN-CONTINUITY (CIC)
APRAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOG, IMPROVES WET WEIGHT ABSORPTION IN SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE (SBS-IF) AND COLON-IN-CONTINUITY (CIC)

Palle Bekker Jeppesen  et al.

SODIUM DEPLETION AND SECONDARY HYPERALDOSTERONISM IN OUTPATIENTS WITH AN ILEOSTOMY: A CROSS-SECTIONAL STUDY
SODIUM DEPLETION AND SECONDARY HYPERALDOSTERONISM IN OUTPATIENTS WITH AN ILEOSTOMY: A CROSS-SECTIONAL STUDY

Palle Bekker Jeppesen  et al.

TRANSFERABILITY OF METABOLIC BALANCE STUDIES IN SHORT BOWEL SYNDROME: ANALYSIS OF DRY MATTER AND ENERGY CONTENTS
TRANSFERABILITY OF METABOLIC BALANCE STUDIES IN SHORT BOWEL SYNDROME: ANALYSIS OF DRY MATTER AND ENERGY CONTENTS

Palle Bekker Jeppesen  et al.

GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOGUE, EXPOSURE DOES NOT CORRELATE WITH HEPATIC INDOCYANINE GREEN CLEARANCE
GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOGUE, EXPOSURE DOES NOT CORRELATE WITH HEPATIC INDOCYANINE GREEN CLEARANCE

Palle Bekker Jeppesen  et al.

EARLY RESPONSE TO GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOG, IN SHORT BOWEL SYNDROME PATIENTS WITH INTESTINAL FAILURE: RESULTS OF 24-WEEK PHASE 3 TRIAL
EARLY RESPONSE TO GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOG, IN SHORT BOWEL SYNDROME PATIENTS WITH INTESTINAL FAILURE: RESULTS OF 24-WEEK PHASE 3 TRIAL

Palle Bekker Jeppesen  et al.

Item 1 - 7 / 7
1